APA (7th ed.) Citation

LM, S., GA, K., KC, A., B, K., & KJ, S. (2026). Use (and Potential for Abuse) of Glucagon-Like Peptide-1 Medications Among Individuals with Eating Disorders: Empirical Review and Clinical Guidance. The Psychiatric clinics of North America, 49(1), 183. https://doi.org/10.1016/j.psc.2025.08.013

Chicago Style (17th ed.) Citation

LM, Schaefer, Kerver GA, Allison KC, Kohoutek B, and Steffen KJ. "Use (and Potential for Abuse) of Glucagon-Like Peptide-1 Medications Among Individuals with Eating Disorders: Empirical Review and Clinical Guidance." The Psychiatric Clinics of North America 49, no. 1 (2026): 183. https://doi.org/10.1016/j.psc.2025.08.013.

MLA (9th ed.) Citation

LM, Schaefer, et al. "Use (and Potential for Abuse) of Glucagon-Like Peptide-1 Medications Among Individuals with Eating Disorders: Empirical Review and Clinical Guidance." The Psychiatric Clinics of North America, vol. 49, no. 1, 2026, p. 183, https://doi.org/10.1016/j.psc.2025.08.013.